Changsheng Pharmaceutical,　located in Taiyangshan Development Zone, Wuzhong, Ningxia, is a technology-driven supplier of pharmaceutical API intermediates. It is committed to providing safe, high-quality products and professional and reliable services for the global pharmaceutical industry and agricultural development industry. Currently, it is mainly engaged in raw materials R&D and sales of drugs and intermediates, pesticide intermediates, spice intermediates and other products, providing customers with process R&D and production services from new product development to product launch.

Changsheng Pharmaceutical was established in 2014 and became a wholly-owned subsidiary of Jiangsu Minghua Hesheng Biotechnology Co., Ltd. in January 2019. The company has more than 150 employees, 40% of whom are technical personnel in R&D and project management. There is a chemical synthesis and analysis testing laboratory in Changzhou, Jiangsu, and a multifunctional pilot laboratory in Wuzhong, Ningxia. The company has always adhered to the strategy of enhancing the company's core competitiveness and sustainable development capabilities by strengthening independent research and development capabilities, and the average annual R&D investment accounts for more than 5% of the company's sales revenue.

The production service of Changsheng Pharmaceutical is an agile manufacturing model. The products we sell have independent intellectual property rights. At the same time, we enjoy the market rights of most of the products authorized by the technology. The company has established a stable production service system through various production organization methods such as investment and shareholding, project cooperation, processing and production, so as to flexibly meet the requirements of different quality assurance systems and process conditions.

Our mission: focus on market challenges and pressures that customers care about, provide customers with high-quality products and professional services, and at the same time focus on tapping the potential of product costs through continuous technological progress to improve customers’ continued competitiveness. "Customers’ success is our success".